Last week our founder, Dr Andrew Chalmers, attended the Pivotal Scientific Networking Meeting in Oxfordshire, UK.
We spoke to Andrew about his experience at the event, and any take home information he thought you, the readers of the CiteAb blog, might find useful.
“The talk that really grabbed my attention was from the Native Antigen Company” said Andrew. “The title of the talk was ‘When your new product selection works really well – our experience with the Zika virus outbreak’, delivered by business development manager Andy Lane.
“The talk outlined the company’s experience in producing the Zika virus NS1 recombinant protein using mammalian expression systems so that the antigen is correctly modified.
“There are 67 members of the Flavivirus family, so developing an understanding of the biology and the issue of specificity of antibodies is key. This was central to the Zika project and led to a phenomenal 400% spike in sales for the Native Antigen Company team.”
In addition to the talks at the event, Andrew said the networking opportunity was great and he’d definitely recommend the event to anyone thinking of attending next year.
In the meantime, if you’re interested in finding out more about the Native Antigen Company you can do so here, and Andrew suggests that they might be worth having a chat with if you’re looking to make some antibodies against viral proteins.
The next Pivotal Scientific Networking Meeting will be held in June 2017 – you can register here: http://www.pivotalscientific.com/pivotal-circle
– Katrina and the CiteAb team